[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"TRiCares\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":86},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,40,66],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100633564","the-tricure-us-ide-pivotal-study-100633564",false,"NCT07528326","The TRICURE US IDE Pivotal Study","TRiCares Topaz Transcatheter Tricuspid Heart Valve Replacement System IDE Pivotal Study","TRICURE US IDE","Inclusion Criteria:\n\n* Patient is ≥ 18 years of age\n* Patient has severe or greater tricuspid regurgitation with symptoms despite optimal medical therapy\n* Patient is an appropriate candidate to undergo TTVR as determined by the Institution Heart Team\n\nExclusion Criteria:\n\n* Patient has a tricuspid device currently in place\n* Patient has anatomical contraindications\n* Patient is in need of urgent surgery\n* Patient has a left ventricular ejection fraction of \\\u003C 25%\n* Patient has life expectancy of \\\u003C 1 year","ALL","18 Years",{"count":20,"type":21},831,"ESTIMATED","INTERVENTIONAL",[24],"NA","The purpose of the study is to evaluate safety and effectiveness of the TRiCares Topaz TTVR system for treatment of subjects presenting with clinically relevant tricuspid regurgitation who are suitable for valve replacement.",[27],"Tricuspid Regurgitation (TR)","NOT_YET_RECRUITING","2026-04-29",{"date":31,"type":32},"2026-05-05","ACTUAL",{"date":34,"type":21},"2026-10",{"date":36,"type":21},"2035-09",{"name":38,"class":39},"TRiCares","INDUSTRY",{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":22,"phases":50,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":56,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},"100560770","the-tricure-eu-pivotal-study-100560770","NCT06581471","The TRICURE EU Pivotal Study","The TRICURE EU PIVOTAL TRiCares Topaz Transcatheter TRICUspid Heart Valve REplacement System EUropean PIVOTAL Study","TRICURE EU","Inclusion Criteria:\n\n* Adult patients\n* Tricuspid regurgitation grade 3 (severe) on a scale of 0 (none) to 5 (torrential)\n* Institutional Heart Team evaluates patient as being at increased operative risk\n\nExclusion Criteria:\n\n* Patient in need of emergent intervention\n* Patient who is hemodynamically unstable\n* Anatomical contraindications for implantation with study device\n* Patient who is currently participating in another clinical investigation where the primary endpoint was not reached yet",{"count":49,"type":21},80,[24],"Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System",[53,54,55],"Tricuspid Valve Regurgitation","Heart Valve Disease","Cardiovascular Diseases","RECRUITING","2026-04-10",{"date":59,"type":32},"2026-04-15",{"date":61,"type":32},"2024-08-29",{"date":63,"type":21},"2030-12-30",{"name":38,"class":39},8,{"id":67,"slug":68,"hasResults":11,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":73,"targetDuration":4,"studyType":22,"phases":75,"briefSummary":51,"conditions":76,"keywords":4,"overallStatus":56,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":78,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},"100555042","the-tricure-efs-study-100555042","NCT06506942","The TRICURE EFS Study","The TRICURE EFS TRiCares Topaz Transfemoral TRICUspid Heart Valve REplacement System Early Feasibility Study","TRICURE EFS",{"count":74,"type":21},15,[24],[53,77,55],"Heart Valve Diseases",{"date":79,"type":32},"2026-04-14",{"date":81,"type":32},"2024-09-11",{"date":83,"type":21},"2031-03",{"name":38,"class":39},9,""]